Table 2 Dosage Scheme of ESAs for “Responders” and “Non-Responders” Anaemic Patients for a two-month period
Active substance | Responders (Hb increase ≥ 1 g/dl) | Non responders (Hb increase < 1 g/dl) | ||
|---|---|---|---|---|
First month treatment | Second month treatment | First month treatment | Second month treatment | |
Darbepoetin α | 150 MCG/week or 500 MCG/3 weeks | 150 MCG/week or 500 MCG/3 weeks | 150 MCG/week or 500 MCG/3 weeks | 300 MCG/week |
Epoetin β | 3 × 10.000 IU/week or 30.000 IU/week | 3 × 10.000 IU/week or 30.000 IU/week | 3 × 10.000 IU/week or 30.000 IU/week | 3 × 20.000 IU/week or 2 × 30.000 IU/week or 1x60.000 IU/week |
Epoetin α | 3 × 10.000 IU/week or 40.000 IU/week or 30.000 IU/week | 3 × 10.000 IU/week or 40.000 IU/week or 30.000 IU/week | 3 × 10.000 IU/week or 40.000 IU/week or 30.000 IU/week | 3 × 20.000 IU/week or 2 × 30.000 IU/week |
Epoetin ζ | 3 × 10.000 IU/week or 40.000 IU/week | 3 × 10.000 IU/week or 40.000 IU/week | 3 × 10.000 IU/week or 40.000 IU/week | 6 × 10.000 IU/week |